Valuation : LivaNova PLC

Market Cap 4.31B 3.71B 3.51B 3.19B 5.98B 411B 6.01B 41.73B 16.05B 209B 16.18B 15.82B 662B P/E 2026 *
19.6x
P/E 2027 * 23.6x
Enterprise Value 4.38B 3.78B 3.58B 3.24B 6.08B 419B 6.11B 42.46B 16.33B 213B 16.46B 16.1B 673B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.59x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 week-4.57%
Current month-2.04%
1 month-3.22%
3 months-1.52%
6 months+31.84%
Current year+27.06%
1 week 77.15
Extreme 77.15
81.83
1 month 77.15
Extreme 77.15
83.52
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 29/02/2024
Director of Finance/CFO 56 30/10/2020
Investor Relations Contact - 31/07/2022
Director TitleAgeSince
Director/Board Member 69 18/10/2015
Chairman 74 08/06/2021
Director/Board Member 62 17/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Sell

Director

-2,300 0.0042%
31/08/26 Sell

Director

-1,650 0.0030%
11/08/26 Exercice

Executive/Senior Manager

38,076 0.0693%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.57%+39.06%+43.13% 4.31B
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -0.33%-5.03%+5.87%+12.44% 56.21B
Weighted average by Cap. -0.69%-4.90%-5.66%+11.09%

Financials

2026 *2027 *
Net sales 1.52B 1.31B 1.24B 1.13B 2.11B 145B 2.12B 14.75B 5.67B 73.98B 5.72B 5.59B 234B 1.63B 1.4B 1.33B 1.21B 2.26B 156B 2.27B 15.8B 6.07B 79.23B 6.12B 5.99B 250B
Net income 226M 195M 185M 167M 314M 21.61B 315M 2.19B 843M 11B 850M 831M 34.75B 187M 161M 152M 138M 259M 17.86B 261M 1.81B 696M 9.08B 702M 687M 28.71B
Net Debt 75M 64.62M 61.19M 55.46M 104M 7.17B 105M 727M 279M 3.65B 282M 275M 11.52B -85M -73.24M -69.34M -62.85M -118M -8.12B -119M -824M -317M -4.13B -319M -312M -13.05B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
11/09/26 US$78.18 0.00% 552,416
10/09/26 US$78.18 -0.95% 426,011
09/09/26 US$78.93 -2.19% 674,359
08/09/26 US$80.70 -1.49% 472,958
04/09/26 US$81.92 +0.89% 334,168
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
78.18USD
Average target price
89.10USD
Spread / Average Target
+13.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!